▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

David Jagielski

TMFdjagielski

David Jagielski, CPA, has been a contributing Motley Fool stock market analyst covering healthcare, consumer staples, consumer discretionary, and technology stocks since 2017. David has more than 10 years of experience in finance roles across businesses of different sizes and sectors. He holds a Certified Public Accountant designation in Canada.

Recent Articles by David Jagielski

A couple counting money.

Oct 4, 2024 by David Jagielski

2 Dividend Growth ETFs That You Can Count on for Recurring Income for Decades

These funds invest in stocks that have proven track records for dividend growth.

Businessman checking his phone.

Oct 4, 2024 by David Jagielski

Up More Than 540% in Just 3 Months, Can Lumen Technologies Stock Still Go Higher?

Is hype fueling Lumen Technologies, or could this be a stock worth buying right now?

A family reviewing financial results with an advisor.

Oct 3, 2024 by David Jagielski

1 Supercharged Vanguard ETF That Can Turn $250 a Month Into $670,000 or More in 25 Years

The Vanguard Information Technology ETF's average annual return was 14%-plus over the past two decades.

A couple of investors looking at a series of charts.

Oct 2, 2024 by David Jagielski

Has Summit Therapeutics Stock Already Peaked?

Summit Therapeutics stock is up a remarkable 700% this year.

Person listening to music on their phone.

Sep 29, 2024 by David Jagielski

Apple's New iPhone 16 Didn't Seem All That Impressive. But Here's Why Its Sales Numbers Could Be Strong.

The iPhone 16 is selling well, according to T-Mobile.

A frustrated investor reviewing multiple charts and reports.

Sep 28, 2024 by David Jagielski

Donald Trump Says He Isn't Planning to Sell DJT Stock. Why That Might Not Be Enough of a Reason to Buy Into Its Sell-Off.

The stock has bigger problems than whether the former president sells his stake or not.

A couple meeting with an advisor.

Sep 27, 2024 by David Jagielski

2 Vanguard ETFs That Dividend Investors Can Buy and Hold Forever

Dividend-focused funds can ensure you're collecting money on a recurring basis while keeping your risk low.

A person using ChatGPT on their laptop.

Sep 26, 2024 by David Jagielski

Is Microsoft's Copilot Proving to Be a Disappointment?

I tried Copilot and wouldn't be surprised if companies aren't impressed with it.

An excited investor looking at a chart.

Sep 24, 2024 by David Jagielski

3 Ultra-Cheap Stocks That Could Get a Boost From Fed Rate Cuts

These stocks are all trading at less than 12 times their estimated future earnings.

A doctor looking at a tablet with another person.

Sep 24, 2024 by David Jagielski

Medical Properties Trust Dumps Steward Health. Is It Safe to Buy the Stock Again?

Medical Properties Trust hopes getting rid of one of its biggest headaches will help its stock turn things around.

A physician using a scale to measure a person's weight.

Sep 23, 2024 by David Jagielski

Amgen vs. Viking Therapeutics: What's the Better GLP-1 Stock to Buy?

These two stocks could be rivals in the intense GLP-1 space in the future.

A person using ChatGPT on their laptop.

Sep 22, 2024 by David Jagielski

3 Artificial Intelligence Stocks Down More Than 50% From Their 52-Week Highs. Could They Be Bargain Buys Right Now?

These companies are still growing their businesses at high rates.

Man meeting with financial advisor at hom

Sep 21, 2024 by David Jagielski

1 Unstoppable Vanguard ETF That Could Turn $400 Per Month Into $1 Million

You don't need to target a sky-high return to achieve significant gains -- you just need to be a disciplined investor.

Warren Buffett with a group of people.

Sep 21, 2024 by David Jagielski

3 Warren Buffett Stocks That Are Beating the Market This Year and Can Still Go Higher

These companies have been delivering some strong numbers in 2024, and their operations are likely to continue to grow in the long run.

Investor pointing at a chart.

Sep 20, 2024 by David Jagielski

1 Struggling Artificial Intelligence Stock That Wall Street Analysts Think Could Rally by More Than 40%

Could UiPath make for an underrated buy right now?

Person shopping for cough medicine in a pharmacy.

Sep 20, 2024 by David Jagielski

3 Reasons Why Walgreens Boots Alliance Stock May Not Be Doomed

Walgreens stock has been a falling knife this year, but the company has levers it can pull on to strengthen its operations.

A couple sitting and using a laptop.

Sep 20, 2024 by David Jagielski

Forget Nvidia: This Top ETF Could Turn $25,000 Into Over $1 Million

The Invesco QQQ Trust has generated massive 400% returns over the past 10 years.

A couple reviewing a statement.

Sep 19, 2024 by David Jagielski

Why Realty Income Might Be 1 of the Best Dividend Stocks You Can Own

There's more to this stock than just its high payout.

A couple using a laptop and reviewing documents.

Sep 19, 2024 by David Jagielski

C3.ai's Chief Says It's a "Mathematical Certainty" That the Company Will Be Profitable. But a Closer Look at the Numbers Says Something Else.

Investors should always rely on their own analysis, not just management talk and projections, when deciding whether to buy a stock.

Person with a headache tracking charts.

Sep 19, 2024 by David Jagielski

This High-Yielding Dividend Stock Just Cut Its Payout for a 2nd Time in a Year

Medical Properties still offers a high yield, but it's drastically lower than what it was a year ago.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services